Our teaching and our students
The School of Biomedical Science and Pharmacy has primary responsibility for the Bachelor of Biomedical Science (including Biomedical Science Honours 2019), as of 2013 the new Bachelor of Pharmacy (Honours) and the Master of Pharmacy. The Bachelor of Biomedical Science has an intake of approximately 100 students per year and is rated by students as one of the University's most sought after degrees. The Master of Pharmacy, which began in 2004, has an intake of approximately 85 students per year and was the first graduate-entry training program for pharmacists to be offered in Australia.
The School also provides teaching in the basic medical sciences (anatomy, physiology, immunology, microbiology, biochemistry, genetics, and pharmacology) in almost every degree delivered by the Faculty of Health and Medicine, as well as some of the degrees offered by the Faculty of Education and Arts, and the Faculty of Science. In total, the School teaches into 71 courses taken by over 1200 full-time equivalent students enrolled in 15 different programs. Students enrolled in study areas as diverse as medicine, nursing, physiotherapy, medical radiation science, podiatry, oral health and exercise and sports science all come into contact with staff of the School of Biomedical Sciences and Pharmacy.
In August 2012 The Dunkley Medal was established and is awarded for 'Excellence in Biomedical Research' by a student graduating with a Bachelor of Biomedical Science (Honours) at the University of Newcastle. It is a distinguished award, not necessarily presented every year, but rather on occasions of outstanding criteria-based achievement.
Our School is one of the University of Newcastle's most research-intensive schools, currently being ranked in the top three in terms of external research funding. Our researchers work on topics as diverse as cancer cell biology; the genetic basis of human diseases; the cell biology of meiosis; the immunological basis of asthma; the neurobiological basis of affective, addictive, sensory and neurodegenerative disorders; improved treatments for stroke and cardiovascular disease; pharmacoeconomics; pharmacy practice; drug development; the development of anti-inflammatory nutraceuticals; and exercise physiology.